Earnings call Monash IVF delivered FY25 underlying NPAT of $27.4M, in line with revised guidance, despite a 5% decline in stimulated cycles and 70bps market share loss. FY26 guidance of $20M–$23M NPAT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback